일회용 요관경 시장 : 시장 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Disposable Ureteroscope Market was valued at USD 310.1 million in 2025 and is estimated to grow at a CAGR of 15.6% to reach USD 1.3 billion in 2035.

The market expansion is influenced by the rising incidence of urolithiasis, continuous advancements in imaging and endoscopic technologies, and growing preference for minimally invasive urological procedures. Increasing adoption across ambulatory surgical centers is also reinforcing demand, as healthcare providers prioritize faster turnaround times and reduced infection risks. Disposable ureteroscopes are single-use endoscopic instruments designed for visualization and treatment of ureter and kidney conditions, offering flexible or semi-rigid configurations with integrated imaging systems. These devices support accurate diagnosis and management of kidney stones, ureteral strictures, and urinary tract tumors while significantly reducing cross-contamination risks and eliminating the need for reprocessing and sterilization. Their operational efficiency and consistent performance are making them increasingly preferred in modern urology practices. In addition, rising healthcare expenditure and expanding access to advanced surgical care in emerging regions are further supporting adoption. The growing shift toward value-based healthcare models is also encouraging the use of cost-efficient single-use devices, contributing to long-term market penetration.

The flexible ureteroscope segment held a share of 81.9% in 2025, supported by strong clinical adoption and superior maneuverability in minimally invasive urological procedures. This segment's leadership is attributed to its ability to provide enhanced navigation and visualization within complex renal structures, making it highly suitable for procedures such as ureteroscopy and retrograde intrarenal surgery. Increasing emphasis on infection control, procedural consistency, and operational efficiency is further driving preference for single-use flexible ureteroscopes across hospitals and ambulatory surgical environments.

The urolithiasis segment reached USD 145.6 million in 2025. Urolithiasis, commonly known as kidney stone disease, affects a significant global population and remains a leading cause of urological interventions. The condition continues to rise due to increasing prevalence of obesity, diabetes, and lifestyle-related dietary changes, which collectively contribute to higher stone formation rates. This growing disease burden is accelerating demand for effective diagnostic and therapeutic solutions. Disposable ureteroscopes are widely utilized in this segment due to their high-definition imaging capabilities, enabling precise detection and treatment of stones within the urinary tract and improving clinical outcomes.

North America Disposable Ureteroscope Market captured 38.7% share in 2025. The region's dominance is supported by a high prevalence of urological conditions such as kidney stones, urinary tract infections, ureteral strictures, and renal cancers. Increasing procedural volumes across hospitals and ambulatory surgical centers are further strengthening demand, as healthcare systems continue to rely on advanced endoscopic solutions for efficient and minimally invasive treatment delivery.

Key players operating in the Global Disposable Ureteroscope Market include Ambu, Becton, Dickinson and Company, Boston Scientific, Coloplast, Cook Medical, Dornier MedTech, Karl Storz, NeoScope, OLYMPUS, OPCOM Medical, OTU Medical, Richard Wolf, STERIS, and Zhuhai Pusen Medical Technology. Companies in the disposable ureteroscope market are actively focusing on product innovation to enhance imaging quality, flexibility, and ergonomic design for improved procedural efficiency. Many manufacturers are investing in advanced digital visualization technologies and integrated imaging systems to support more accurate diagnosis and treatment outcomes. Strategic collaborations with hospitals and ambulatory surgical centers are being used to expand product adoption and strengthen distribution networks. Firms are also prioritizing cost optimization strategies to make single-use devices more accessible across diverse healthcare settings. Expansion into emerging healthcare markets is supporting revenue diversification and broader geographic reach.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation for any one approach
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Application trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of urolithiasis & kidney stone disease globally
    • 3.2.1.2 Technological advancements in disposable endoscopes
    • 3.2.1.3 Increasing preference for minimally invasive urological procedures
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of ureteroscopy procedures
    • 3.2.2.2 Insurance coverage and reimbursement challenges in emerging markets
  • 3.2.3 Market opportunities
    • 3.2.3.1 Expansion into emerging markets with growing urology infrastructure
    • 3.2.3.2 Miniaturization for pediatric and complex anatomical applications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by primary research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East and Africa
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends
• 3.7 Patent landscape (Driven by primary research)
• 3.8 Investment and funding analysis
• 3.9 Cost-effectiveness analysis: disposable vs. reusable ureteroscopes
• 3.10 Impact of AI & Generative AI on the Market
  • 3.10.1 AI-driven disruption of existing business models
  • 3.10.2 GenAI use cases and adoption roadmap by segment
  • 3.10.3 Risks, Limitations and regulatory considerations
• 3.11 Porter's analysis
• 3.12 PESTEL analysis
• 3.13 Customer insights (Driven by primary research)
• 3.14 Start-up scenarios
• 3.15 Value chain analysis
• 3.16 Gap analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis (Driven by primary research)
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Flexible ureteroscope
• 5.3 Rigid ureteroscope

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Urolithiasis
• 6.3 Urethral stricture
• 6.4 Kidney cancer
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Ambu
• 9.2 Becton, Dickinson and Company
• 9.3 Boston Scientific
• 9.4 Coloplast
• 9.5 Cook Medical
• 9.6 Dornier MedTech
• 9.7 Karl Storz
• 9.8 NeoScope
• 9.9 OLYMPUS
• 9.10 OPCOM Medical
• 9.11 OTU Medical
• 9.12 Richard Wolf
• 9.13 STERIS
• 9.14 Zhuhai Pusen Medical Technology